まとめ
黄の患者における癌胚性抗原 (CEA) 濃度の上昇は,がんではなく,良性胆道阻害を示すことが多い. CEAレベルは,肝機能検査と相関し,阻害解消後に正常化しました.
科学分野:
- 肝臓病理学 肝臓病理学
- 胃腸内科 胃腸内科
- 腫瘍学 腫瘍学
背景:
- 癌胚性抗原 (CEA) の上昇は,しばしば悪性腫瘍と関連しています.
- 胆道阻害などの良性疾患は,CEAレベルにも影響を及ぼします.
- 良性肝疾患におけるCEAの行動を理解することは,正確な診断に不可欠です.
研究 の 目的:
- 循環する癌胚性抗原 (CEA) レベルと,良性肝臓外胆道閉塞の患者における肝機能検査との関係を調査する.
- 黄患者におけるCEA濃度の上昇が悪性疾患または良性疾患の兆候であるかどうかを判断する.
主な方法:
- 29人の黄患者で,良性の肝臓外胆道閉塞および炎症を研究した.
- 循環中の癌胚性抗原 (CEA) レベルを測定した.
- 血清アルカリリンフォスファターゼとビリルビンを含む肝機能検査を評価した.
- 障害の解消前と後のCEAレベルをモニタリングする.
主要な成果:
- 52%の患者は,閉塞中のCEA濃度 (>2.5ng/ml) が上昇していた.
- 高いCEAは,胆管石や胆管炎で発生する頻度が,胆管石や胆管炎で発生する頻度よりも高い.
- 血清アルカリリンフォスファタゼとビリルビンの濃度は,CEAが上昇した患者で有意に高かった.
- CEAレベルは,障害の解消後,患者の70%で正常化しました.
結論:
- 黄患者における循環中の癌胚性抗原 (CEA) 濃度の上昇は,良性胆道阻害および炎症と関連付けられる.
- CEAレベルは,これらの患者の肝機能テストの異常と相関しています.
- 阻害性黄の文脈におけるCEAの上昇は必ずしも癌を暗示するものではなく,臨床文脈の重要性を強調しています.
さらに関連する動画
関連する概念動画
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...


